Cover Image

PAPERBACK
$47.95



View/Hide Left Panel

Committee on Nutrition. 1985. Composition of human milk: Normative data. In: Pediatric Nutrition Handbook, 2nd ed. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 363–368.

Dalton TA, Berry RS. 1992. Hepatotoxicity associated with sustained-release niacin. Am J Med 93:102–104.

Dillon JC, Malfait P, Demaux G, Foldihope C. 1992. Urinary metabolites of niacin during the course of pellagra. Ann Nutr Metab 36:181–185.


Einstein N, Baker A, Galper J, Wolfe H. 1975. Jaundice due to nicotinic acid therapy. Am J Dig Dis 20:282–286.

Estep DL, Gay GR, Rappolt RT Sr. 1977. Preliminary report of the effects of propranolol HCl on the discomfiture caused by niacin. Clin Toxicol 11:325–328.

Etchason JA, Miller TD, Squires RW, Allison TG, Gau GT, Marttila JK, Kottke BA. 1991. Niacin-induced hepatitis: A potential side effect with low-dose time-release niacin. Mayo Clin Proc 66:23–28.


Ferenchick G, Rovner D. 1989. Case report: Hepatitis and hematemesis complicating nicotinic acid use. Am J Med Sci 298:191–193.

Ford JE, Zechalko A, Murphy J, Brooke OG. 1983. Comparison of the B vitamin composition of milk from mothers of preterm and term babies. Arch Dis Child 58:367–372.

Fraunfelder FW, Fraunfelder FT, Illingworth DR. 1995. Adverse ocular effects associated with niacin therapy. Br J Ophthalmol 79:54–56.

Frost PH. 1991. All niacin is not the same. Ann Intern Med 114:1065.

Fu CS, Swendseid ME, Jacob RA, McKee RW. 1989. Biochemical markers for assessment of niacin status in young men: Levels of erythrocyte niacin coenzymes and plasma tryptophan. J Nutr 119:1949–1955.


Gass JD. 1973. Nicotinic acid maculopathy. Am J Ophthalmol 76:500–510.

Gibbons LW, Gonzalez V, Gordon N, Grundy S. 1995. The prevalence of side effects with regular and sustained-release nicotinic acid. Am J Med 99:378–385.

Goldsmith GA. 1958. Niacin-tryptophan relationships in man and niacin requirement. Am J Clin Nutr 6:479–486.

Goldsmith GA, Sarett HP, Register UD, Gibbens J. 1952. Studies on niacin requirement in man. 1. Experimental pellagra in subjects on corn diets low in niacin and tryptophan. J Clin Invest 31:533–542.

Goldsmith GA, Rosenthal HL, Gibbens J, Unglaub WG. 1955. Studies on niacin requirement in man. 2. Requirement on wheat and corn diets low in tryptophan . J Nutr 56:371–386.

Goldsmith GA, Gibbens J, Unglaub WG, Miller ON. 1956. Studies on niacin requirement in man. 3. Comparative effects of diets containing lime-treated and untreated corn in the production of experimental pellagra. Am J Clin Nutr 4:151–160.

Goldstein MR. 1988. Potential problems with the widespread use of niacin. Am J Med 85:881.

Gray DR, Morgan T, Chretien SD, Kashyap ML. 1994. Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med 121:252– 258.


Henderson LM, Gross CJ. 1979. Metabolism of niacin and niacinamide in perfused rat intestine. J Nutr 109:654–662.

Henkin Y, Johnson KC, Segrest JP. 1990. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin. J Am Med Assoc 264:241– 243.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement